loadpatents
name:-0.0044631958007812
name:-0.0026969909667969
name:-0.00053596496582031
Gonzalez Cantalapiedra; Esther Patent Filings

Gonzalez Cantalapiedra; Esther

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gonzalez Cantalapiedra; Esther.The latest application filed is for "tricyclic compounds for use as kinase inhibitors".

Company Profile
0.2.3
  • Gonzalez Cantalapiedra; Esther - Madrid N/A ES
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Tricyclic compounds for use as kinase inhibitors
Grant 9,682,991 - Pastor Fernandez , et al. June 20, 2
2017-06-20
Tricyclic Compounds for Use as Kinase Inhibitors
App 20130065881 - Pastor Fernandez; Joaquin ;   et al.
2013-03-14
Imidazopyridazines for Use as Protein Kinase Inhibitors
App 20110046127 - Pevarello; Paolo ;   et al.
2011-02-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed